Head-to-head
Oak Longevity vs Care Bare Rx
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. Oak Longevity is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; Care Bare Rx is $199. Over twelve months that is $1,596 against $2,388. Value Scores are 95.6 and 70.9 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · Care Bare Rx plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and Care Bare Rx is $199 — $66 apart, or $792 across a year. Over twelve months the totals are $1,596 (billed monthly) and $2,388 (billed monthly).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Care Bare Rx charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Oak Longevity | Rank | Care Bare Rx | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $199 | 16/32 | Oak Longevity by $66 |
| 0.5 mg | $133 | 3/21 | $199 | 11/21 | Oak Longevity by $66 |
| 1 mg | $133 | 3/21 | $199 | 11/21 | Oak Longevity by $66 |
| 1.7 mg | $133 | 3/21 | $199 | 11/21 | Oak Longevity by $66 |
| 2.4 mg | $133 | 3/29 | $199 | 13/29 | Oak Longevity by $66 |
Oak Longevity is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and Care Bare Rx sits 12. There are 9 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Oak Longevity is $4 above the cheapest semaglutide program on record. Care Bare Rx is $70 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, Care Bare Rx by $150. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | Care Bare Rx | Cheaper |
|---|---|---|---|
| Month to month | $133 | $199 | Oak Longevity by $66 |
| Settled dose | Oak Longevity | Care Bare Rx | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $2,388 | $792 apart |
| 0.5 mg | $1,596 | $2,388 | $792 apart |
| 1 mg | $1,596 | $2,388 | $792 apart |
| 1.7 mg | $1,596 | $2,388 | $792 apart |
| 2.4 mg | $1,596 | $2,388 | $792 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term; Care Bare Rx publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $2,388 on Care Bare Rx. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 95.6 for Oak Longevity and 70.9 for Care Bare Rx, against a semaglutide category floor of $129. Oak Longevity leads by 24.7 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| Care Bare Rx | 45.4 | 10.5 | 10 | 5 | 70.9 |
Where the two programs differ
All-in monthly
Oak Longevity is cheaper month to month — $133 against $199, a gap of $66 every month, or $792 across a year if both rates hold.
Cancellation terms
Cancellation differs: Oak Longevity states Cancel before renewal, while Care Bare Rx states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Oak Longevity asks for Month-to-month; Care Bare Rx asks for Monthly (confirm at enrollment). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Oak Longevity's figure is provider-stated and Care Bare Rx's is reported. Oak Longevity rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $2,388 for Care Bare Rx. Oak Longevity is lower by $792 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
Care Bare Rx Official site
Care Bare Rx is a cash-pay compounded GLP-1 telehealth service offering both semaglutide and tirzepatide from $199/mo. It operates a lighter clinical model — confirm prescriber availability and refill cadence before enrolling.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are Monthly (confirm at enrollment); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, 2026 capture
Watch: Lighter clinical model; confirm prescriber availability, refill cadence and pharmacy identity before enrolling. Reported status from RangeYourself 2026 data.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
Care Bare Rx carries tirzepatide at $199 a month and semaglutide at $199 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
Care Bare Rx does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Oak Longevity and Care Bare Rx for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Care Bare Rx carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Oak Longevity Official site wins this matchup. And if you would rather trust a better-evidenced number, oak longevity's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; Care Bare Rx's is reported as of 2026-07-14.
Questions
Is Oak Longevity or Care Bare Rx cheaper for semaglutide?
Oak Longevity is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $199, a difference of $66 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus Care Bare Rx?
Oak Longevity works out to $1,596 across twelve months and Care Bare Rx to $2,388, on the plan terms each publishes.
Does Oak Longevity or Care Bare Rx raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. Care Bare Rx: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and Care Bare Rx differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and Care Bare Rx names its pharmacy?
Neither. Oak Longevity records Partner 503A pharmacy (not publicly itemized) and Care Bare Rx records Partner 503A pharmacy (not named publicly). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Oak Longevity and Care Bare Rx prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. Care Bare Rx's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · Care Bare Rx official site. Compounded tirzepatide and semaglutide are not FDA-approved products.